Literature DB >> 27192590

Molecular characterization of Mycobacterium tuberculosis isolates from Tehran, Iran by restriction fragment length polymorphism analysis and spoligotyping.

Seifu Gizaw Feyisa1, Mehri Haeili2, Fatemeh Zahednamazi3, Nader Mosavari4, Mohammad Mohammad Taheri4, Gholamreza Hamzehloo5, Samin Zamani3, Mohammad Mehdi Feizabadi3.   

Abstract

INTRODUCTION Characterization of Mycobacterium tuberculosis (MTB) isolates by DNA fingerprinting has contributed to tuberculosis (TB) control. The aim of this study was to determine the genetic diversity of MTB isolates from Tehran province in Iran. METHODS MTB isolates from 60 Iranian and 10 Afghan TB patients were fingerprinted by standard IS6110-restriction fragment length polymorphism (RFLP) analysis and spoligotyping. RESULTS The copy number of IS6110 ranged from 10-24 per isolate. The isolates were classified into 22 clusters showing ≥ 80% similarity by RFLP analysis. Fourteen multidrug-resistant (MDR) isolates were grouped into 4 IS6110-RFLP clusters, with 10 isolates [71% (95% CI: 45-89%)] in 1 cluster, suggesting a possible epidemiological linkage. Eighteen Iranian isolates showed ≥ 80% similarity with Afghan isolates. There were no strains with identical fingerprints. Spoligotyping of 70 isolates produced 23 distinct patterns. Sixty (85.7%) isolates were grouped into 13 clusters, while the remaining 10 isolates (14.2%) were not clustered. Ural (formerly Haarlem4) (n = 22, 31.4%) was the most common family followed by Central Asian strain (CAS) (n = 18, 25.7%) and T (n = 9, 12.8%) families. Only 1strain was characterized as having the Beijing genotype. Among 60 Iranian and 10 Afghan MTB isolates, 25% (95% CI: 16-37) and 70% (95% CI: 39-89) were categorized as Ural lineage, respectively. CONCLUSIONS A higher prevalence of Ural family MTB isolates among Afghan patients than among Iranian patients suggests the possible transmission of this lineage following the immigration of Afghans to Iran.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27192590     DOI: 10.1590/0037-8682-0405-2015

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  7 in total

1.  Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran.

Authors:  Noormohamad Mansoori; Farzam Vaziri; Sirus Amini; Sharareh Khanipour; Shahin Pourazar Dizaji; Masoumeh Douraghi
Journal:  Infect Drug Resist       Date:  2020-07-01       Impact factor: 4.003

2.  Comparison of hspX gene sequence in the Beijing and non-Beijing Mycobacterium tuberculosis.

Authors:  Ashkan Seyed Majidi; Hadi Bazzazi; Samin Zamani; Ezzat Allah Ghaemi
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-09-09

3.  Role of MIRU-VNTR and spoligotyping in assessing the genetic diversity of Mycobacterium tuberculosis in Henan Province, China.

Authors:  Jie Shi; Danwei Zheng; Yankun Zhu; Xiaoguang Ma; Shaohua Wang; Hui Li; Jin Xing
Journal:  BMC Infect Dis       Date:  2018-09-03       Impact factor: 3.090

4.  Resistance of Mycobacterium tuberculosis strains to Rifampicin: A systematic review and meta-analysis.

Authors:  Seifu Gizaw Feyisa; Ahmed Abdulahi Abdurahman; Worku Jimma; Eshetu Ejeta Chaka; Jalil Kardan-Yamchi; Hossein Kazemian
Journal:  Heliyon       Date:  2019-01-01

Review 5.  Role of Immigration in Tuberculosis Transmission to Iran: A Systematic Review.

Authors:  Amir Mohammadzadeh; Jalil Rashedi; Behroz Mahdavi Poor; Hossein Samadi Kafil; Mahya Pourostadi; Abdolhassan Kazemi; Mohammad Asgharzadeh
Journal:  Int J Prev Med       Date:  2020-12-30

6.  Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis.

Authors:  Shima Hadifar; Abolfazl Fateh; Vahid Pourbarkhordar; Seyed Davar Siadat; Shayan Mostafaei; Farzam Vaziri
Journal:  BMC Infect Dis       Date:  2021-01-04       Impact factor: 3.090

7.  Challenge in direct Spoligotyping of Mycobacterium tuberculosis: a problematic issue in the region with high prevalence of polyclonal infections.

Authors:  Mansour Kargarpour Kamakoli; Sharareh Khanipour; Shima Hadifar; Hasan Ghajavand; Ghazaleh Farmanfarmaei; Abolfazl Fateh; Seyed Davar Siadat; Farzam Vaziri
Journal:  BMC Res Notes       Date:  2018-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.